Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soblidotin in advanced soft tissue sarcoma
NCT00064220Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Apr 2003
- Primary completion
- Dec 2005
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of soblidotin in soft tissue sarcoma (STS), sponsored by Daiichi Sankyo Co., Ltd.. Started Apr 2003; status: completed.
02
Drugs
soblidotin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00064220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00064220.